Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 37, Issue 5, Pages 1174-1183Publisher
WILEY
DOI: 10.1002/eji.200636504
Keywords
dendritic cells; IFN consensus sequence binding protein; IRF-8; TGF-beta 1; transforming growth factor
Categories
Ask authors/readers for more resources
Langerhans cells (LC) represent the cutaneous contingent of dendritic cells (DC). Their development critically depends on transforming growth factor beta 1 (TGF-beta 1) as demonstrated by analysis of TGF-beta 1(-1-) mice, which lack LC. Here we used a two-step culture system and transcriptional profiling by DNA microarrays to search for TGF-beta 1 target genes in DC. The study identified interferon regulatory factor 8 (IRF-8) as a novel target gene of TGF-beta 1 signaling in DC. TGF-beta 1 effectively induced Smad2/3 phosphorylation and IRF-8 RNA and protein expression. Blocking the TGF-beta 1/Smad pathway by ectopic expression of inhibitory Smad7 and by SB431542 inhibitor abolished TGF-beta 1 induced up-regulation of IRF-8. Furthermore, TGF-beta 1-dependent induction of IRF-8 occurred in the absence of protein biosynthesis, suggesting a direct action of TGF-beta 1/Smad signaling on IRF-8 gene activity. TGF-beta 1 also induced expression of the chemokine receptor CCR7 and enhanced DC migration towards CCR7 ligand ELC. DC of IRF-8(-/-) mice show reduced CCR7 expression and migratory activity, thereby implicating the TGF-beta 1/Smad/IRF-8 signaling pathway in CCR7 regulation. Thus, this study identified a novel TGF-beta 1/Smad/IRF-8 signaling pathway with an impact on DC phenotype and function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available